跳至主要内容
临床试验/ISRCTN21187408
ISRCTN21187408进行中(未招募)未知

Intrahepatic cholestasis of pregnancy: diagnosis and perinatal outcomes

icolae Testemi?anu State University of Medicine and Pharmacy0 个研究点目标入组 100 人开始时间: 2020年6月3日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

性别
Female

入选标准

  • 1. ICP (pruritus with a raised serum bile acid above 10 µmol/l) for the main group
  • 2. Absence of ICP (absence of pruritus and normal serum bile acid (below 10 µmol/l)) for the control group
  • 3. At least 22+0 weeks of gestation on day of recruitment
  • 4. No known lethal fetal anomaly
  • 5. Aged 18 years or over
  • 6. Able to give written informed consent

排除标准

  • 1. Women with known liver disease: acute viral hepatitis, autoimmune hepatitis, Wilson's disease, primary sclerosing cholangitis, primary biliary cirrhosis, symptomatic cholelithiasis, cytomegalovirus, Epstein-Barr virus, acute fatty liver of the pregnancy, drug-induced hepatitis
  • 2. Women diagnosed with preeclampsia, HELLP syndrome and congenital thrombophilia

研究者

发起方
icolae Testemi?anu State University of Medicine and Pharmacy

相似试验